Genomic Sequencing in Oncology: From Bench to Bedside
-
Register
- Non-member - $50
- Member - $40
- *Further discounts may apply once you log in.
Already registered?
Log in now.
This presentation explores the role of neuroimaging biomarkers in the early detection and diagnosis of Alzheimer's disease. We discuss advanced imaging techniques such as PET-CT, MRI, and amyloid imaging, and their utility in identifying preclinical and prodromal stages of Alzheimer's disease.
Key:
Complete
Next
Failed
Available
Locked